Nanohale AG (ETR:FYB) | WebDisclosure

PRESS RELEASE

published on 05/07/2025 at 09:37, 1 year 1 month ago

Formycon invites to conference call on the results of the first quarter of 2025 and announces participation in international investor conferences
Formycon AG to discuss Q1 2025 results in a conference call and participate in investor conferences. Details and webcast link available. Biosimilar development focus

Conference Call Investor Conferences Formycon AG Biosimilars Q1 2025 Results
BRIEF

published on 03/27/2025 at 06:35, 1 year 3 months ago

Formycon AG prévoit un exercice 2024 solide et une croissance continue en 2025

Formycon AG Prévisions De Revenus Biosimilaires Exercice Financier 2024 Positionnement Sur Le Marché
BRIEF

published on 03/27/2025 at 06:35, 1 year 3 months ago

Formycon AG Sees Strong Fiscal Year 2024, Eyes Continued Growth in 2025

Market Position Revenue Forecast Financial Year 2024 Formycon AG Biosimilars
PRESS RELEASE

published on 03/27/2025 at 06:30, 1 year 3 months ago

Formycon reports on a successful financial year 2024 with strong operational progress and continuous strengthening of its market position
Formycon reports successful financial year 2024 with strong operational progress and market position enhancement. Key milestones achieved in biosimilar development. Financial outlook for 2025 provided

Market Position Financial Year 2024 Financial Outlook Biosimilar Formycon
BRIEF

published on 03/24/2025 at 06:35, 1 year 3 months ago

Formycon AG Announces Conference Call and Event Participation

Financial Results Conference Call Formycon Investor Events International Conferences
BRIEF

published on 03/24/2025 at 06:35, 1 year 3 months ago

Formycon AG annonce une conférence téléphonique et une participation à un événement

Résultats Financiers Conférence Téléphonique Conférences Internationales Formycon Événements Pour Les Investisseurs
PRESS RELEASE

published on 03/24/2025 at 06:30, 1 year 3 months ago

Formycon invites to conference call on the results of the financial year 2024 and announces participation in international investor conferences in the 2nd quarter of 2025
Formycon announces conference call for fiscal year 2024 results and participation in investor conferences in Q2 2025

Conference Call Investor Conferences Financial Year 2024 Biosimilars Formycon
BRIEF

published on 03/03/2025 at 14:05, 1 year 3 months ago

FYB202/Otulfi® Biosimilar Launched in the U.S. and EU

Healthcare Access Ustekinumab Biosimilar Launch Market Availability Cost-effective Therapy
BRIEF

published on 03/03/2025 at 14:05, 1 year 3 months ago

Lancement du biosimilaire FYB202/Otulfi® aux États-Unis et dans l'UE

Ustekinumab Accès Aux Soins De Santé Lancement D'un Biosimilaire Disponibilité Sur Le Marché Thérapie Rentable
PRESS RELEASE

published on 03/03/2025 at 14:00, 1 year 3 months ago

FYB202/Otulfi® (ustekinumab-aauz), a biosimilar to Stelara®, launched in the United States and the European Union
FYB202/Otulfi® (ustekinumab-aauz), a biosimilar to Stelara®, officially launched in the United States and European Union, offering comparable efficacy and safety. Formycon AG and Fresenius ensure successful market access

Formycon AG Launch Biosimilar Stelara Otulfi

Published on 06/27/2026 at 16:50, 1 day 15 hours ago

Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 2 days 6 hours ago

Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 2 days 8 hours ago

Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 2 days 9 hours ago

Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 2 days 9 hours ago

Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada

View all ACCESSWIRE

Published on 06/29/2026 at 08:05, 11 minutes ago

Update on voluntary public offer by NNS for OCI
Published on 06/29/2026 at 08:00, 16 minutes ago

MHM Corporate - Assemblée générale du 30 juin 2026 : Réunion probablement en 2ème convocation
Published on 06/29/2026 at 08:00, 16 minutes ago

MHM Corporate - General Meeting of June 30, 2026: likely to be held on second call due to lack of quorum
Published on 06/29/2026 at 08:00, 16 minutes ago

Transaction in Own Shares
Published on 06/29/2026 at 08:00, 16 minutes ago

Aquis Stock Exchange: Updated Application for Admission Announcement

View all EQS

Published on 06/26/2026 at 17:45, 2 days 14 hours ago

Combined General Meeting, June 25, 2026
Published on 06/26/2026 at 17:45, 2 days 14 hours ago

Assemblée générale mixte du 25 juin 2026
Published on 06/26/2026 at 17:45, 2 days 14 hours ago

Descriptif du programme de rachat d'actions
Published on 06/26/2026 at 14:44, 2 days 17 hours ago

Safran information
Published on 06/26/2026 at 14:44, 2 days 17 hours ago

Information Safran

View all LES ECHOS COMFI WIRE

News